2017 NTD Summit: Global resolve to end neglected tropical diseases amid unprecedented progress

5 May 2017

The following are links to summaries and key outcomes from the 2017 NTD Summit

  • A summary of the outcome of the 2017 NTD Summit in Geneva published by WHO:

Apart from celebrating 10 years of multi-stakeholder collaboration, today’s event also marked the fifth anniversary of the London Declaration. New announcements to strengthen the global resolve to eliminate and eradicate these diseases were made, including:

  • An investment of £360 million (approximately US$ 460 million) to implement NTD programmes over the next five years by the Government of the United Kingdom of Great Britain and Northern Ireland;
  • Grants of US$ 335 million from the Bill & Melinda Gates Foundation over the next four years (2017–2020);
  • Pledges of €25 million (approximately US$ 26.8 million) (2017–2025) from the Government of Belgium to support the elimination of human African trypanosomiasis (sleeping sickness), plus an additional €10 million for five years (2025 – 2030);
  • A pledge from EMS – the biggest domestic manufacturer of generic medicines in Brazil – to donate the oral antibiotic azithromycin to support WHO in the eradication of yaws;
  • The donation by Vestergaard of tiny target traps for the control of tsetse flies that transmit sleeping sickness;
  • A renewed pledge by the Japanese pharmaceutical company EISAI to donate diethylcarbamazine until the global elimination of lymphatic filariasis as a public health problem has been achieved; and
  • The donation by the Mundo Sano Foundation (Argentina) of benznidazole for the paediatric treatment (for patients aged up to 19 years) of Chagas disease.


  • An announcement from MSD and MDP: 


  • Togo becomes first country to eliminate LF in Africa: 


  • Great story published by Devex on the key takeaways from the Geneva NTD Summit: